MedPath

Application of cultured autologous keratinocytes in combination with a meshed split skin autograft for burn wound healing

Phase 2
Completed
Conditions
deep (third degree) burn wounds
10014982
Registration Number
NL-OMON35395
Lead Sponsor
niversitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

-competent and temporarily incompetent patients 18 years of age or older with acute burn wounds that require widely meshed skin grafting, which do not need immediate excision
- minimal study wound area 100 cm2
- maximal study wound area 300 cm2
- maximal TBSA 50% full thickness wounds
-Informed consent

Exclusion Criteria

- Immunocompromised patients
- Infected wounds
- Use of high doses of (.20mg/pd) corticosteroids and/or cytostatica
- Known penicillin allergy
- Conditions where the patient is non compliant as judged by a medical specialist

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The % of wound closure after 7 days. Wound closure will be monitored by an<br /><br>experienced surgeon. The exact area will be assessed using computerized<br /><br>planimetric determination. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Scar quality at three and 12 months after operation will be assessed using the<br /><br>POSAS, cutometer to measure scar elasticity, dermaspectometer to assess scar<br /><br>colour and Primos 3D to assess the smoothness of the scar. </p><br>
© Copyright 2025. All Rights Reserved by MedPath